rsv/flu-01e
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 10, 2023 (NCT05970744)
Timeline
Indications
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06890429 | Phase 2 | Dec 7, 2023 | Pavlov First Saint Petersburg State Medical University, Research Institute of Influenza, Russia |
| NCT05970744 | Phase 1 | May 10, 2023 | Research Institute of Influenza, Russia |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Research Institute of Influenza, Russia | Academic/Hospital | 2 | 2 | 2 | 2023 |
| Pavlov First Saint Petersburg State Medical University | Academic/Hospital | 1 | 0 | 1 | 2023 |
2 organizations
Page 1 / 1